President Biden announced Tuesday there will be ample COVID-19 vaccine for "every adult in America" to be protected by the end of May. That milestone previously was set for late July, but the pace has accelerated due to Johnson & Johnson's single-dose vaccine receiving emergency use authorization.

As they help to vaccinate the nation against COVID-19, pharmacies are compiling loads of consumer information on people who schedule appointments.

A December 2020 opinion issued by Washington Attorney General (AG) Bob Ferguson affirmed pharmacists’ standard of practice under collaborative drug therapy agreements (CDTAs).

FDA granted emergency use authorization (EUA) to Janssen’s single-dose COVID-19 vaccine on Saturday, February 27, for adults ages 18 years and older.

Johnson & Johnson received FDA emergency use authorization late Saturday for its coronavirus vaccine, which is recommended in a single dose for adults aged 18 years and older. Not only is the need for a booster injection eliminated, but the new vaccine also will not have to remain frozen until use.